ESR1 and hepatocellular carcinoma: Furthermore, the prenylated flavonoid icaritin, currently undergoing phase 3 clinical trials for the treatment of advanced hepatocellular carcinoma, has been shown to be able to modulate the splice variant of ERα, ERα-36, and by acting on the apoptosis/autophagy crosstalk, to carry out significant antitumor activity [168].